Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Bap1/SMN axis in Dpp4+ skeletal muscle mesenchymal cells regulates the neuromuscular system
Ji-Hoon Kim, Jong-Seol Kang, Kyusang Yoo, Jinguk Jeong, Inkuk Park, Jong Ho Park, Joonwoo Rhee, Shin Jeon, Young-Woo Jo, Sang-Hyeon Hann, Minji Seo, Seungtae Moon, Soo-Jong Um, Rho Hyun Seong, Young-Yun Kong
Ji-Hoon Kim, Jong-Seol Kang, Kyusang Yoo, Jinguk Jeong, Inkuk Park, Jong Ho Park, Joonwoo Rhee, Shin Jeon, Young-Woo Jo, Sang-Hyeon Hann, Minji Seo, Seungtae Moon, Soo-Jong Um, Rho Hyun Seong, Young-Yun Kong
View: Text | PDF
Research Article Cell biology Muscle biology

Bap1/SMN axis in Dpp4+ skeletal muscle mesenchymal cells regulates the neuromuscular system

  • Text
  • PDF
Abstract

The survival of motor neuron (SMN) protein is a major component of the pre-mRNA splicing machinery and is required for RNA metabolism. Although SMN has been considered a fundamental gene for the central nervous system, due to its relationship with neuromuscular diseases, such as spinal muscular atrophy, recent studies have also revealed the requirement of SMN in non-neuronal cells in the peripheral regions. Here, we report that the fibro-adipogenic progenitor subpopulation expressing Dpp4 (Dpp4+ FAPs) is required for the neuromuscular system. Furthermore, we also reveal that BRCA1-associated protein-1 (Bap1) is crucial for the stabilization of SMN in FAPs by preventing its ubiquitination-dependent degradation. Inactivation of Bap1 in FAPs decreased SMN levels and accompanied degeneration of the neuromuscular junction, leading to loss of motor neurons and muscle atrophy. Overexpression of the ubiquitination-resistant SMN variant, SMNK186R, in Bap1-null FAPs completely prevented neuromuscular degeneration. In addition, transplantation of Dpp4+ FAPs, but not Dpp4– FAPs, completely rescued neuromuscular defects. Our data reveal the crucial role of Bap1-mediated SMN stabilization in Dpp4+ FAPs for the neuromuscular system and provide the possibility of cell-based therapeutics to treat neuromuscular diseases.

Authors

Ji-Hoon Kim, Jong-Seol Kang, Kyusang Yoo, Jinguk Jeong, Inkuk Park, Jong Ho Park, Joonwoo Rhee, Shin Jeon, Young-Woo Jo, Sang-Hyeon Hann, Minji Seo, Seungtae Moon, Soo-Jong Um, Rho Hyun Seong, Young-Yun Kong

×

Figure 7

Deubiquitination of SMN by Bap1.

Options: View larger image (or click on image) Download as PowerPoint
Deubiquitination of SMN by Bap1.
(A) Relative expression of SMN in FAPs ...
(A) Relative expression of SMN in FAPs from hind limb muscles of 1.5-week-old Bap1WT and Bap1ΔMPC mice. Gapdh and b-actin were used for normalization in quantitative PCR analysis. n = 4 animals for each group; Mann-Whitney U test; data are mean ± SEM. (B) Immunoblot of Bap1 and SMN in FAPs from 4-week-old Bap1WT and Bap1ΔMPC mice. (C) Immunoblot of Bap1 and SMN after immunoprecipitation (IP) analysis. IP was performed with pre-immune IgG, anti-Bap1, or anti-SMN antibodies. Each sample was blotted with each indicated antibody. (D) Ubiquitination assay of SMN following BAP1 overexpression. Flag-tagged BAP1 was expressed in HEK293T cells with HA-Ubiquitin (HA-Ub) and HisMax-tagged SMN (His-SMN). Cell lysates were subjected to pull-down assays with NTA resins followed by immunoblot. (E) Ubiquitination assay of SMN following BAP1 or BAP1C91S overexpression. HEK293T cells expressing Flag-tagged BAP1 or its C91S mutant were subjected to IP with anti-SMN antibody. After IP, each sample was blotted with each indicated antibody. (F) Ubiquitination assay of SMN and its lysine-substitution variants. HisMax-tagged variants (K41R, K51R, or K186R) were expressed in HEK293T cells with or without HA-Ub. Cell lysates were subjected to pull-down assays with NTA resins followed by immunoblot with each indicated antibody. (G) Immunoblot of SMN in Bap1WT or Bap1ΔMPC FAPs transduced with lentiviral vectors containing His-tagged SMNWT or SMNK186R. Samples were blotted with each indicated antibody. (H) Immunoblot analysis of SMN protein half-life. Bap1ΔMPC FAPs transduced with lentiviral vectors containing His-tagged SMN or its K186R mutant were subjected to immunoblot with indicated antibodies. Cells were incubated with cycloheximide (CHX) for the indicated times. (I) A schematic model for deubiquitination of SMN1 by BAP1. (D, F, and G) For MG132 treatment, cells were incubated with 10 μM MG132 for 4 hours before the preparation of cell lysates.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts